Mbx Biosciences, Inc. · NASDAQ:MBX
Azoulay Salomon sold 70,003 Mbx Biosciences, Inc. shares (Form 4)
Traded May 8, 2026 · Filed May 11, 2026
On May 8, 2026, Azoulay Salomon (Chief Medical Officer) sold 70,003 Mbx Biosciences, Inc. shares at an average US$38.36 for US$2.69M under a trading plan, leaving 14,769 shares. Filed May 11, 2026 (Form 4).
- Sold
- 70,003 shares
- Price
- US$38.36 average (US$38.30 to US$38.38)
- Value
- US$2.69M
- Holding after
- 14,769 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 8, 2026 | Common Stock | Option exercise | 55,000 | US$10.46 | 69,769 | Direct |
| May 8, 2026 | Common Stock | Sale | 55,000 | US$38.38 | 14,769 | Direct |
| May 8, 2026 | Common Stock | Option exercise | 15,003 | US$16.00 | 29,772 | Direct |
| May 8, 2026 | Common Stock | Sale | 15,003 | US$38.30 | 14,769 | Direct |
Source
Related
- Mbx Biosciences, Inc.
- Azoulay Salomon
- Mbx Biosciences, Inc. shareholders
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Azoulay Salomon · May 8, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Aug 10, 2026
- Form 4 · Smither John W · Aug 4, 2026
- Form 4 · Hoerter Steven L. · Aug 4, 2026